{"name":"Fresenius Medical Care","slug":"fresenius-medical","ticker":"FME","exchange":"XETRA","domain":"freseniusmedicalcare.com","description":"Fresenius Medical Care AG & Co. KGaA is a German healthcare company which provides kidney dialysis services through a network of 4,171 outpatient dialysis centers, serving 345,425 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo dialysis 3 times per week for the rest of their lives.","hq":"Bad Homburg, Germany","founded":1996,"employees":"108165","ceo":"Helen Giza","sector":"Dialysis & Renal Care","stockPrice":36.99,"stockChange":0.46,"stockChangePercent":1.26,"marketCap":"$11.6B","metrics":{"revenue":22614829476.03579,"revenueGrowth":-5.5,"grossMargin":26,"rdSpend":0,"netIncome":1103592299.9482944,"cash":1447599253.494528,"dividendYield":4.08,"peRatio":11.3,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2028-06-01","label":"Peritoneal Dialysis Solution patent cliff ($1.5B at risk)","drug":"Peritoneal Dialysis Solution","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Solution for Peritoneal Dialysis","genericName":"Solution for Peritoneal Dialysis","slug":"solution-for-peritoneal-dialysis","indication":"Peritoneal dialysis for patients with end-stage renal disease","status":"phase_3"}]}],"pipeline":[{"name":"Solution for Peritoneal Dialysis","genericName":"Solution for Peritoneal Dialysis","slug":"solution-for-peritoneal-dialysis","phase":"phase_3","mechanism":"This solution helps remove waste products from the blood by exchanging fluids in the peritoneal cavity.","indications":["Peritoneal dialysis for patients with end-stage renal disease"],"catalyst":""}],"recentEvents":[{"date":"2024-02-01","type":"earnings","headline":"Fresenius Medical Care Reports Strong Q4 2023 Earnings","summary":"Fresenius Medical Care reported strong Q4 2023 earnings, driven by growth in its dialysis and renal care business.","drugName":"","sentiment":"positive"},{"date":"2023-09-01","type":"deal","headline":"Fresenius Medical Care Acquires Majority Stake in NxStage Medical","summary":"Fresenius Medical Care acquired a majority stake in NxStage Medical, a leading provider of home dialysis solutions.","drugName":"","sentiment":"positive"},{"date":"2023-06-01","type":"regulatory","headline":"FDA Approves Fresenius Medical Care's New Dialysis Machine","summary":"The FDA approved Fresenius Medical Care's new dialysis machine, which features advanced technology and improved patient outcomes.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTE5UOURkVzNTMmtrVFlua3hNVERWVlFUYXRzNk5jaDJ1RE9ieWlJeEtlSTFFSnZYWjRxMzBpcXpxTGpsSWp4NDVjbEJOTWYxdklTMmVnYVBRcU1ZbmlRQkV1MGxR?oc=5","date":"2026-04-02","type":"pipeline","source":"ChartMill","summary":"FME.DE Stock Price, Quote & Chart | FRESENIUS MEDICAL CARE AG (FRA:FME) - ChartMill","headline":"FME.DE Stock Price, Quote & Chart | FRESENIUS MEDICAL CARE AG (FRA:FME)","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-03-26","type":"pipeline","source":"simplywall.st","summary":"Fresenius Medical Care (XTRA:FME) Valuation Check After Recent Share Price Reset - simplywall.st","headline":"Fresenius Medical Care (XTRA:FME) Valuation Check After Recent Share Price Reset","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNeHRCUk5uRkdxY0ZpV25uMmxwMl9GRWhmM0FFRFJ6STJ2N3BWREx2WWRQSi1IRFJSZmlOdldDbm5nOU1oSkwyUnNmLXVsR3VsN0RtbGZadmZHNnJMU0kwRmNQQkE3eTFsMVVOYURXN1E0YTRubE9fWkJWY1dfUnNsbDJISlMyUE9Y?oc=5","date":"2026-03-05","type":"pipeline","source":"Investors' Chronicle","summary":"How to invest in the healthcare revival - Investors' Chronicle","headline":"How to invest in the healthcare revival - Investors' Chronicle","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxNaXp5eVdKclZyUkpaMXA1cjhQWUpDUHhyZlh5cUhtZTFtcXdSTjBTV1dPNTdNZV9sTVhnc296Y0NlVjJMcU5QNVFIelRvSFRyWjBfdzFIX2RsX3VWaW5vdkFJNURjanZVTk5KenJ4bDRVY3lVQTdkLW1KeDR6bmpSVGlqeDhoMV9ObzRBUF94UVFLb3VlRGc4N3Y3bC1CX0JaYnhFVzdmeTJ0Z3cyMEVsTmU0ejdsRFpJVHNQdWt2Yw?oc=5","date":"2026-02-24","type":"pipeline","source":"Reuters","summary":"Fresenius Medical Care's meek 2026 guidance sends shares falling - Reuters","headline":"Fresenius Medical Care's meek 2026 guidance sends shares falling","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE5reS1ZdnBHamRYSkpiejFXWG9GaVhMdHFabm5yR202aF9BejJmcUlia2dxQ0lLa3llVGxhSXQ2bndNZXRDZUpUbWRrUE9TZWdQTGh2bVhhamNsYzVpYjI4U2IwMEctMlhsNHliN2d30gFyQVVfeXFMT2ZTSzNBWFc1Zi1VSEhHSG5yNDdCbk5vVVp5Z19fV0lhR19IcUl0MUE3NXdCZEZnSkdUT3ZrbktlRGUwVmZFdWxGWm92aUhVRlRWLUg2R1FoS0N0YUl0ZkZ0XzRQY1VIZVdmeG9JOU9JT1dB?oc=5","date":"2026-02-23","type":"pipeline","source":"koreabiomed.com","summary":"Fresenius Korea, nephrology society sign MOU to expand HVHDF access - koreabiomed.com","headline":"Fresenius Korea, nephrology society sign MOU to expand HVHDF access","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgJBVV95cUxNZVpnUzdwaWJqSjVjdXZTOWVjMDhuRFV5M0pITDA1ZG1BOHMtcUdCTHpLTzAzU0pNZUUzZ01SLU02bVhfcHJJZXJsdFRKMThVWThyNUFfN3o5T3Z2OHhQNHJZRlRJVUZod2wzblRtSzJTYXZmbm94QVpualNKb1NGN3NYZ09ScTJSNUdUV3FZLUtHcmRXTFdaZWc0Z2lxUjFsRlNXNkV5YmgxUnlZMmg1U3ZQR29aY0podWk3MDBpcm1JNjVDSFlZQ0M2Y09nTlNKQ21tSVM0VEhtdllGdXFyYWJUNDJLbDJXQlY4OTQ0NXNnczRZeVcwMmcyMGJ4VWp1T3MzNHpPTVhkVnMwSEJLMks2ZXl3aS1yZHNHdlROcENVSEZlVWc?oc=5","date":"2026-01-09","type":"deal","source":"PR Newswire","summary":"Fresenius Medical Care accelerates the second tranche of its EUR 1 billion share buyback program with around EUR 415 million repurchase planned - PR Newswire","headline":"Fresenius Medical Care accelerates the second tranche of its EUR 1 billion share buyback program with around EUR 415 mil","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxNRjYxaVhzQng4aEh4SmJHaEtVSDBkbkZSb3F3dDlhSmdGclpCWlRsMndVOTh1TWtxQnFVeEp6elAyNkh1M2tpS0JtZWVJT3VOMHoyTUFqVmR5d3lNQTNfbEloZDhIcjZOb1hEYzBfWGwwZ3Zyak91dGgtNDRMcUpKMnhEdGxzUGM2RnRPekJXZUtrRmpNQ0k2eWwtOVpiVm5EMXhGQ2dBaUZnMmwySE9DUktoQ3RNSE5hQXNJa0dB?oc=5","date":"2025-10-24","type":"pipeline","source":"TradingView","summary":"Reasons to Hold Fresenius Medical Stock in Your Portfolio for Now - TradingView","headline":"Reasons to Hold Fresenius Medical Stock in Your Portfolio for Now","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwJBVV95cUxObnRJeHVOVVNjUV9yVmZpbnZQeWVNYUVLd1JFUDlQR0hsUnhzekpWWnNodzc4WFVkWEY3QkZhT3hxWjhqM2R4MnRMb05DbU1fWEZzNmNPRWFhdHdWeHNrb1o0c0Z6NTVjQlZqQUk1bDBOMGMwZHc2Y21YZk5KQ2drRXNIdWJjYTIyZWNiMFRBN1V3YXhxMFM2TUFTQ3pmb0JLamJsRk9JNUdpTEo2bEtiWkx0dHJSaDVZcnJ6RFExR3hsZHlZbndPNUJ1bHR5UzBpSDRsZk41VzFqYmN3TElXaF9OYnBJa3g5TmZhYXFfTDlpUkI2UFBkdmtIdDF0NnJ2ZVpXeFQtSUpjTE9iWVVwa2ZLdXZaaHVyNnhZR3hhOFVwQ0lwcVpaRFhPaXYyYnBaaFU4d0hkUmoyc0ZScmdtdXFuMA?oc=5","date":"2025-09-18","type":"pipeline","source":"PR Newswire","summary":"Fresenius Medical Care advances its FME Reignite strategy by increasing ownership in its Value-Based Care asset and appointing a new leader for the operating segment - PR Newswire","headline":"Fresenius Medical Care advances its FME Reignite strategy by increasing ownership in its Value-Based Care asset and appo","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywJBVV95cUxPcndiZ0tQVmh4S0dTVmszd3EzUWNsRGg2SWpLOXVrQ1dGajB1dW14aGJYN1l0TzRNSmpvTWZxSExyWEdrNFpKXzJtSEdtWU9TTGlzbWM1UVVqMG9yWFktWTFhMVgyNG5EeEsyS2RVand4cmJQUVJMYTVQcXdxVEhqd3hkeHAwMjlhbEZkY2JGTFNZc2dDTVlsWDRSc2dLWlNoYzBVTjRaTExyUHpZVUJrcGJyT3BibzRhUENoNVhxYzNrSkQyUUdwU3FMTHB2Xzg1aWZCQjZkb2daZlJZUjdYVHl1S1dEZnRza0pUUHVIYWc0QmVFVE92d1QwM0pHWkZxa3JQcDJ3RTA4a21jRWQ1T0NEdTdkUUNRQ0xBSlEtTW1ZbTFxMVlvNFJ6bXIzMTN0eG11dFRBUnhwb3BNb0prY1lxdTByZkw2QzhJ?oc=5","date":"2025-06-17","type":"earnings","source":"PR Newswire","summary":"Fresenius Medical Care Launches its Strategy FME Reignite with increased Profitability Aspirations, and a New Capital Allocation Framework to further enhance Value Creation - PR Newswire","headline":"Fresenius Medical Care Launches its Strategy FME Reignite with increased Profitability Aspirations, and a New Capital Al","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-wFBVV95cUxOeFFnY1VydHhwbngzMW1mcHFkTnlMNnMwMUE4bHVDSFBlRUlGVlRucFR4azdNQ2R2Y2tIQUpQbGVPQlpvOGZKN0hxRzlBdHBSRW9xQTloTzQtblM2SlpheFlmODhVTVk0RWVBcFlKZElNUjRRMVFQUEJrUmRWNlIydDdyVFhFUmJjeTY2OFVULW9GRXJWWnVqcURHOVhCVlJhd3E2NGcwZnRlNGUxZGxhcnVfY2F1ZDFBZzlEaTk4WHc4ZHB5a3ZuZUFCZWJwTjNRQ3d4RHpHalVVSUxaOFcxcjVfcnZrbHJHOVYxVGdEYnY1dEt6QVVXUDQ3cw?oc=5","date":"2025-02-25","type":"earnings","source":"Fresenius Medical Care","summary":"Fresenius Medical Care delivers 18% earnings growth in 2024 and continues the acceleration momentum into 2025 - Fresenius Medical Care","headline":"Fresenius Medical Care delivers 18% earnings growth in 2024 and continues the acceleration momentum into 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxOLUdZYVBLMEp2SHZJa2hqbXp3Rk90OXpacjhEWVBOSDRyTGFCZlVFVEpNQl9wbTQxcnc1cTN5Qi1OVUZPTWtZXy1ydGRBQ05taEdNNG4yV09oY1RMLVJ0VklqMnJZc2hQUFpWSnBDRTVMSVlRZzZ4cUNubEwycTVsRkJ3clItOWxrek1FUG1idERVSmxxLVRDWmpzZnpuTnBVRXlvU0VydVFwMHNQRU5BVEdPVnlqUl9RZVFoeEFySUktMF93dmEzZ3JpcllhSG1yYnIxSmo0YXE?oc=5","date":"2024-11-06","type":"pipeline","source":"The Guardian","summary":"‘If they don’t get care, they die’: the woman who runs the world’s largest kidney dialysis company | Healthcare industry - The Guardian","headline":"‘If they don’t get care, they die’: the woman who runs the world’s largest kidney dialysis company | Healthcare industry","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxOeFV6aUU4RkZSTUVrTlg1aTRXSUJFM0Rwc1JPTnRETEFTOW9oUGZTTkJJMWZoaUdSSHNROWoxRHNyY3dyUThyek1UbXQ4R3QwSXVCTnl2TTFnWDNOSzZuVDNhc0tSbFFxakprbVBocEw4RlZXdnFtV0FNVFJXSnUzM2xmaVBGckcxYWUzejZST2ROX3FaamZB0gGcAUFVX3lxTE1aWVdyam9pb1hqQkpRamptdmpFbi1Yby1leEt5LWJoaVdYMXNyYmRjUHZjdjFwM1JIMENKTk8wTGtaMzB6YWhVVjlta1NiVnBtTEJvNDJCaXZ1WU1rYksxRzZFZjdMMnJ2V3hkMGh5YXc5YV9ub0FndlIwVHBkUVJWenpvZ3p4TUhBaUxjWld3TWZPZEpLMl80LU5hQg?oc=5","date":"2024-08-21","type":"pipeline","source":"Consulting.us","summary":"Fresenius Medical Care appoints ex-consultant Anna Long - Consulting.us","headline":"Fresenius Medical Care appoints ex-consultant Anna Long","sentiment":"neutral"},{"date":"2021-09-02","type":"earnings","source":"SEC EDGAR","summary":"SC 13D filed with SEC: SC 13D","headline":"SC 13D Filing","sentiment":"neutral"},{"date":"2006-02-10","type":"earnings","source":"SEC EDGAR","summary":"SC 13G filed with SEC","headline":"SC 13G Filing","sentiment":"neutral"},{"date":"2005-02-14","type":"earnings","source":"SEC EDGAR","summary":"SC 13G filed with SEC","headline":"SC 13G Filing","sentiment":"neutral"}],"patents":[{"drugName":"Peritoneal Dialysis Solution","drugSlug":"peritoneal-dialysis-solution","patentNumber":"","type":"Patent Cliff","expiryDate":"2028-06-01","territory":"US","annualRevenue":1500000000}],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["DaVita Inc.","Dialysis Clinic Inc.","Baxter International Inc."],"therapeuticFocus":["Dialysis and Renal Care"],"financials":{"source":"sec_edgar+yahoo","revenue":22929441607.1286,"revenuePeriod":"2025-12-31","revenueHistory":[{"period":"2025-12-31","value":22929441607.1286},{"period":"2024-12-31","value":22588678756.388702},{"period":"2023-12-31","value":22726188102.293102},{"period":"2022-12-31","value":22661234831.2131}],"grossProfit":5874917060.7747,"grossProfitHistory":[{"period":"2025-12-31","value":5874917060.7747},{"period":"2024-12-31","value":5556836453.0436},{"period":"2023-12-31","value":5753510518.621501},{"period":"2022-12-31","value":5716926406.4427}],"rdSpend":184550233.79250002,"rdSpendHistory":[{"period":"2025-12-31","value":184550233.79250002},{"period":"2024-12-31","value":214360981.47990003},{"period":"2023-12-31","value":270992990.87100005},{"period":"2022-12-31","value":267084112.36320004}],"sgaSpend":3542906544.8904004,"operatingIncome":2134140188.6232002,"operatingIncomeHistory":[{"period":"2025-12-31","value":2134140188.6232002},{"period":"2024-12-31","value":1714228973.334},{"period":"2023-12-31","value":1725051403.2492},{"period":"2022-12-31","value":1699455608.8362002}],"netIncome":1142952103.7181,"netIncomeHistory":[{"period":"2025-12-31","value":1142952103.7181},{"period":"2024-12-31","value":628403037.8859},{"period":"2023-12-31","value":582940421.0271001},{"period":"2022-12-31","value":786688084.7415}],"eps":3.36,"epsHistory":[{"period":"2025-12-31","value":3.36},{"period":"2024-12-31","value":1.83},{"period":"2023-12-31","value":1.7},{"period":"2022-12-31","value":2.3}],"cash":1848735982.7874002,"cashHistory":[{"period":"2025-12-31","value":1848735982.7874002},{"period":"2024-12-31","value":1344564253.4121},{"period":"2023-12-31","value":1608674066.7075002},{"period":"2022-12-31","value":1488068926.4241002}],"totalAssets":36217678767.2919,"totalLiabilities":19532154221.2332,"totalDebt":12611688094.201502,"equity":15548869171.317602,"operatingCashflow":3132008180.0757003,"operatingCashflowHistory":[{"period":"2025-12-31","value":3132008180.0757003},{"period":"2024-12-31","value":2787551404.0992002},{"period":"2023-12-31","value":3071029208.0643},{"period":"2022-12-31","value":2531984815.1097}],"capex":-1069356309.2667001,"capexHistory":[{"period":"2025-12-31","value":-1069356309.2667001},{"period":"2024-12-31","value":-817007009.9994},{"period":"2023-12-31","value":-799761682.8828001},{"period":"2022-12-31","value":-845780374.5084001}],"freeCashflow":2062651870.8090003,"dividendsPaid":-493592290.11450005,"buybacks":-683744159.4255,"employees":108165,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[{"sga":874927570.7934,"ebit":351420561.0288,"ebitda":892240654.9194001,"period":"2026-03-31","revenue":5388022200.572101,"epsBasic":0.43,"netIncome":137300233.7547,"rdExpense":44753504.7087,"epsDiluted":0.43,"grossProfit":1377911216.0556002,"operatingIncome":438732476.9865},{"sga":916615654.9389001,"ebit":709672897.764,"ebitda":1146067757.9262002,"period":"2025-12-31","revenue":5922412387.915501,"epsBasic":1.14,"netIncome":382100467.59540004,"rdExpense":45127336.4847,"epsDiluted":1.14,"grossProfit":1621929907.8396,"operatingIncome":641328271.5411},{"sga":824112150.192,"ebit":579046729.4352001,"ebitda":996403038.1803001,"period":"2025-09-30","revenue":5706600471.8550005,"epsBasic":null,"netIncome":321024532.9671,"rdExpense":44098130.8764,"epsDiluted":null,"grossProfit":1451189253.4974,"operatingIncome":586120327.5717001},{"sga":925209112.8897,"ebit":522353972.3805,"ebitda":960712617.5910001,"period":"2025-06-30","revenue":5597795565.225901,"epsBasic":0.77,"netIncome":263165888.06100002,"rdExpense":44528037.418800004,"epsDiluted":0.77,"grossProfit":1418646029.1723,"operatingIncome":460748832.14430004},{"sga":876969626.8698001,"ebit":404635514.3424,"ebitda":865339953.9633001,"period":"2025-03-31","revenue":5702633182.1322,"epsBasic":0.52,"netIncome":176660046.87030002,"rdExpense":50796729.012600005,"epsDiluted":0.52,"grossProfit":1383151870.2654002,"operatingIncome":445943925.59040004},{"sga":null,"ebit":null,"ebitda":null,"period":"2024-12-31","revenue":null,"epsBasic":0.23,"netIncome":null,"rdExpense":null,"epsDiluted":0.23,"grossProfit":null,"operatingIncome":null}]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":36.99,"previousClose":36.53,"fiftyTwoWeekHigh":54.02,"fiftyTwoWeekLow":34.57,"fiftyTwoWeekRange":"34.57 - 54.02","fiftyDayAverage":38.74,"twoHundredDayAverage":40.96,"beta":0.82,"enterpriseValue":24040416916.428596,"forwardPE":8.4,"priceToBook":0.78,"priceToSales":0.51,"enterpriseToRevenue":1.06,"enterpriseToEbitda":7.94,"pegRatio":0.77,"ebitda":3028269759.431962,"ebitdaMargin":13.4,"freeCashflow":1953649347.3573122,"operatingCashflow":3206848002.565479,"totalDebt":12902092571.069338,"debtToEquity":77.8,"currentRatio":1.21,"returnOnAssets":3.6,"returnOnEquity":7.9,"analystRating":"2.9 - Hold","recommendationKey":"hold","numberOfAnalysts":17,"targetMeanPrice":44.04,"targetHighPrice":67,"targetLowPrice":31,"dividendRate":1.49,"payoutRatio":0.44,"fiveYearAvgDividendYield":2.98,"exDividendDate":1779408000,"insiderHeldPercent":28.6,"institutionHeldPercent":44.7,"sharesOutstanding":268564630,"floatShares":184689210,"sharesShort":0,"shortRatio":0,"shortPercentOfFloat":0,"epsTrailing":3.27,"epsForward":4.42,"revenuePerShare":67.53,"bookValue":47.66,"officers":[{"age":57,"name":"Ms. Helen  Giza","title":"Chair of Management Board & CEO"},{"age":47,"name":"Mr. Martin  Fischer","title":"CFO & Member of the Management Board"},{"age":53,"name":"Mr. Craig  Cordola FACHE, M.B.A., M.H.A.","title":"CEO of Care Delivery & Member of Management Board"},{"age":55,"name":"Dr. Jorg  Haring","title":"Member of the Management Board, Global Head of Legal,Compliance & Human Resources and Labor Director"},{"age":57,"name":"Mr. Joseph E. Turk Jr.","title":"CEO of Care Enablement & Member of Management Board"},{"age":55,"name":"Dr. Charles  Hugh-Jones M.D.","title":"Global Chief Medical Officer & Member of Management Board"},{"age":null,"name":"Dr. Dominik  Heger","title":"Executive VP and Head of Investor Relations, Strategic Development & Communications"},{"age":null,"name":"Mr. Joachim  Weith","title":"Senior Vice President of Corporate Communications & Governmental Affairs"}],"industry":"Medical Care Facilities","irWebsite":"","website":"https://www.freseniusmedicalcare.com","phone":"49 6172 609 0"}}